Login
Login     |     Register     |     Recover Username/Password

General Investing

BDCs Triangle Capital (TCAP), Medley Capital (MCC) and THL Credit (THL) Profit in the Lower Middle Market

December 18, 2012

Smaller business development companies like Triangle Capital (TCAP), Medley Capital (MCC) and THL Credit (THL) play to the lower end of the middle market and obtain a better risk/reward relative to their BDC peers in the upper end of the middle market, says Greg Mason, CFA, Managing Director & Senior Equity Analyst at Stifel, Nicolaus & Co., Inc.

Triangle’s main focus is on companies that have EBITDA between $5 million and $15 million, which we think is a sweet spot for the lower end of the middle market,” Mason says. TCAP has a sucessful track record, capital to invest and a lower expense ratio than many of its peers, and Mason expects meaningul earnings growth.

He also says Medley and THL, besides playing to the lower end of the middle market, are interesting because of the potential for a SBIC license. He says the process is nearing its end, and once the process is finished, the companies are small enough for this catalyst to be meaningful for their earnings and ability to grow the dividend.

“We think both of those companies with the combination of good management teams focused on the lower end of the middle market with the potential of the SBIC catalyst for earnings and dividends creates a pretty compelling story as well,” Mason said.


TSWT - Subscribe now!

The Wall Street Transcript is a completely unique resource for investors and business researchers.

Over 20,000 CEO, Equity Analyst and Money Manager Interviews

TWST Newsletter

Weekly email with New In-Depth Interviews

Most Popular Interviews
Opportunities in Hepatitis C and Genomic Technologies
David Ferreiro

Published April 26, 2014 in Biotechnology and Pharmaceuticals

Buy ($75)
Investing in Health Care Innovation
Finny Kuruvilla

"We’re a faith-based and socially responsible investing firm"

Published May 16, 2013 in Investing in Health Care

Buy ($75)
A Health Sciences Fund with a Long-Term Focus
Mark W. Oelschlager

"The fund is about $40 million in assets"

Published May 16, 2013 in Investing in Health Care

Buy ($75)
High-Yield Canadian Power Companies
John McIlveen

Published May 14, 2013 in High-Yield Equity Securities

Buy ($75)
Most Popular Reports
Investing in Health Care

Published May 16, 2013

Topics Covered: Health Care - Electronic Health Record Adoption - Biotechnology and Pharmaceutical Investing - Biotechnology and Pharmaceuticals - Biotechnology and Pharmaceutical Companies Valuation - Platform Interoperability and Data Analytics - HITECH Act Incentives - Affordable Care Act
Buy ($175)
Internet Services

Published May 10, 2013

Topics Covered: Increased Mobile Content Traffic - Chinese Online Monetization Trends - Internet Infrastructure and Services Consolidation - Social Networking Economics -
Buy ($175)
Investing Strategies

Published May 10, 2013

Topics Covered: Investing in Financial Services - Long-Term Investing - Large Cap Investing - Value Investing - High Quality Companies - Bottom-up Investing - All-Cap Growth Investing - Investing in Emerging Markets
Buy ($175)
Top Company Interviews
TWST
Register for a Free Account to gain greater access to The Wall Street Transcript right now